pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
BAUSCH · news · pharmadog
← back to BAUSCH
News mentioning BAUSCH
11
stories
1d
FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
biospace
2d
FDA warns Bausch and Lomb, Indian API maker for GMP issues
raps
22d
Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial
biopharma dive
23d
Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail
biospace
24d
Bausch + Lomb plans Phase 3 trial for dry eye drop, despite missing mid-stage goal
endpoints
Aug 5, 26
Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring
fiercebiotech
Aug 3, 26
STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states
stat
Jul 15, 26
STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with states
stat
Jul 10, 26
Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injector
endpoints
Jun 10, 26
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
biopharma dive
Jun 8, 26
City banks nearly $100M for next-gen RNAi drugs
biopharma dive
